A Review and Assessment of Potential Sources of Ethnic Differences in Drug Responsiveness
Authors:
- 1 September 2003
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 43 (9) , 943-967
Abstract
The International Conference on Harmonization (ICH) E5 guidelines were developed to provide a general framework for evaluating the potential impact of ethnic factors on the acceptability of foreign clinical data, with the underlying objective to facilitate global drug development and registration. It is well recognized that all drugs exhibit significant intersubject variability in pharmacokinetics and pharmacologic response and that such differences vary considerably among individual drugs and depend on a variety of factors. One such potential factor involves ethnicity. The objective of the present work was to perform an extensive review of the world literature on ethnic differences in drug disposition and responsiveness to determine their general significance in relation to drug development and registration. A few examples of suspected ethnic differences in pharmacokinetics or pharmacodynamics were identified. The available literature, however, was found to be heterologous, including a variety of study designs and research methodologies, and most of the publications were on drugs that were approved a long time ago.Keywords
This publication has 170 references indexed in Scilit:
- Clinical Pharmacokinetics and Pharmacodynamics of CelecoxibClinical Pharmacokinetics, 2000
- The Significance of the Homozygous CYP2A6 Deletion on Nicotine Metabolism: A New Genotyping Method of CYP2A6 Using a Single PCR–RFLPBiochemical and Biophysical Research Communications, 1999
- Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral AdministrationClinical Pharmacokinetics, 1999
- Use of β ‐ Adrenergic Receptor Blockers in BlacksThe Journal of Clinical Pharmacology, 1996
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Ethnic Differences in Drug Disposition and ResponsivenessClinical Pharmacokinetics, 1991
- Racial Differences in Drug ResponseNew England Journal of Medicine, 1989
- Racial Background and Lidocaine PharmacokineticsThe Journal of Clinical Pharmacology, 1982
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978
- Disease and Acetylation PolymorphismClinical Pharmacokinetics, 1977